FundedIQ
Biotechnology

Cognition Therapeutics: Funding, Investors & Team (Oct 2026)

A neuroscience business called Cognition Therapeutics, Inc. is now in the trial stages of researching medications to aid in restoring normal cellular damage responses in neurodegenerative and neuro-ophthalmic illnesses.

www.cogrx.com LinkedIn Pittsburgh, United States 51-100 employees
Biotechnology Life Science Therapeutics
Total raised
$6.0M
Rounds
1
Latest
Undisclosed round
Nov 2022

Cognition Therapeutics has raised $6.0M across 1 funding round on record, the most recent an undisclosed round of $6.0M announced in Nov 2022.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Cognition Therapeutics Company Profile and Key Stats

Total funding raised
$6.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$6.0M in Nov 2022
Employees
51-100
reported band
Headquarters
Pittsburgh, United States

Latest funding round on record: Nov 2022.

Cognition Therapeutics Funding Rounds

Date
Round
Amount
Undisclosed round
$6.0M

Cognition Therapeutics Founders and Leadership Team

Name
Role
Contact
Lisa Ricciardi
CEO
Locked

Contact details for the Cognition Therapeutics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Cognition Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Cognition Therapeutics' latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Cognition Therapeutics in Biotechnology and Pittsburgh

Companies Similar to Cognition Therapeutics

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Cognition Therapeutics Funding FAQs

What does Cognition Therapeutics do?

A neuroscience business called Cognition Therapeutics, Inc. is now in the trial stages of researching medications to aid in restoring normal cellular damage responses in neurodegenerative and neuro-ophthalmic illnesses.

How much funding has Cognition Therapeutics raised?

Cognition Therapeutics has raised $6.0M across 1 round on record. The most recent is an undisclosed round of $6.0M announced in Nov 2022.

When did Cognition Therapeutics last raise funding?

Cognition Therapeutics' most recent funding round on record is an undisclosed round of $6.0M, announced in Nov 2022.

Who is the CEO of Cognition Therapeutics?

Lisa Ricciardi is listed as CEO at Cognition Therapeutics.

Where is Cognition Therapeutics headquartered?

Cognition Therapeutics is based in Pittsburgh, Pennsylvania, United States.

How many employees does Cognition Therapeutics have?

Cognition Therapeutics is in the 51-100 employee band.

How does Cognition Therapeutics' funding compare to other Biotechnology startups?

Cognition Therapeutics' latest round of $6.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Cognition Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cognition Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.